SBC logo

SBC MEDICAL GROUP HOLDINGS I

SBCNASDAQ
πŸ† #2946 by market capEarnings Nov 12US Equity
$4.84β–Ό $0.18 (βˆ’3.68%)
πŸŒ… Pre-market$4.84β–² 0.00%Regular close Β· extended-hours price shown
πŸ””
Track SBC
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 3.7%
7dβ–Ό 0.2%
14dβ–² 7.6%
30dβ–² 20.1%
ytdβ–² 13.1%
1yβ–² 12.7%
🏦Market Cap
$498M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-15.5%
Declining
πŸ“ŠGross Margin
71.3%
High
πŸ’΅FCF Margin
42.8%
Strong
βš–οΈP/S Ratio
3.0x
Cheap
Otter Score
76
Good

Trading Snapshot

Day Range
$4.82 – $4.91
52-Week Range
$2.78 – $5.30
Volume
$2.00B
Avg Volume
$2.39B
Shares Outstanding
102.8M
Next Earnings
Nov 30, 2026

Fundamentals Snapshot

Annual Revenue
$174M
Last Q Revenue
$49M
P/E Ratio
10.7
P/S Ratio
3.0x
EPS (TTM)
$0.48
Dividend Yield
0.00%
Dilution (1yr)
βˆ’0.2%

Why Investors Own SBC

  • βœ“High-growth profile β€” revenue up +14.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 42% gross margin and 13% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

SBC logo

SBC MEDICAL GROUP HOLDINGS I

SBC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$174Mβ–Ό βˆ’15.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
73.3%β–Ό βˆ’3.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$67Mβ–Ό βˆ’4.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$37Mβ–² +112.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
102.6Mβ–Ό βˆ’0.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$112Mβ–Ό βˆ’$692K YoY
StockOtter Β· stockotter.space

About SBC MEDICAL GROUP HOLDINGS I

SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as orchestrating marketing and advertising campaigns, offering extensive human resources solutions including talent acquisition and staff training, and streamlining appointment scheduling for franchisee clinics. Furthermore, SBC Medical Group facilitates real estate arrangements for both employee housing and clinic facility rentals, oversees the design and construction of new clinics, and manages the procurement of essential medical equipment and supplies. Additionally, the firm furnishes IT software solutions. The broad spectrum of aesthetic and reconstructive procedures facilitated by SBC Medical Group's supported clinics encompasses both surgical and non-surgical interventions. These include popular treatments such as breast augmentation, liposuction, and various rejuvenation therapies targeting wrinkles, acne, scars, and signs of aging. The offerings also extend to specialized procedures like laser skin toning, double fold eye surgery, rhinoplasty, hair transplants, laser hair removal, cosmetic dental work, tattoo removal, and advanced eye procedures like LASIK, among others. Established in 2000, SBC Medical Group Holdings Incorporated maintains its headquarters in Irvine, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
76/100

Analyst Ratings

β“˜
Consensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

GlobeNewsWireΒ·5d ago

SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026

IRVINE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (β€œThe Company” or β€œSBC Medical”), a Medical Services Organization (MSO) providing management support across a wide

Defense WorldΒ·8d ago

Analyzing UnitedHealth Group (NYSE:UNH) and SBC Medical Group (NASDAQ:SBC)

SBC Medical Group (NASDAQ: SBC - Get Free Report) and UnitedHealth Group (NYSE: UNH - Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the streng

Defense WorldΒ·14d ago

Critical Review: 111 (NASDAQ:YI) and SBC Medical Group (NASDAQ:SBC)

SBC Medical Group (NASDAQ: SBC - Get Free Report) and 111 (NASDAQ: YI - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength o

Newsfile CorpΒ·20d ago

SBC Medical to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto

Irvine, California--(Newsfile Corp. - September 10, 2026) - SBC Medical Group Holdings Incorporated (NASDAQ: SBC) ("The Company" or "SBC Medical"), a Medical Services Organization (MSO) providing management support acros

Business WireΒ·28d ago

SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC Medical will be conducting a Non-Deal Roadshow (NDR) and participating in several investor conferences throughout September 2026.

MarketBeatΒ·Aug 30

SBC Medical Group Re-Accelerates Growth as EBITDA Surges 32% in Q2

SBC Medical Group NASDAQ: SBC said its growth re-accelerated in the second quarter of 2026 following structural reforms undertaken in 2025, with profit growth exceeding revenue growth as the company expanded management s